Edition:
India

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

6.05USD
18 Jan 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$6.05
Open
$6.10
Day's High
$6.20
Day's Low
$5.95
Volume
221,094
Avg. Vol
266,454
52-wk High
$6.25
52-wk Low
$1.50

Select another date:

Mon, Dec 11 2017

BRIEF-Sorrento Therapeutics Enteres Into Securities Purchase Agreement

* SORRENTO THERAPEUTICS SAYS ON DEC 11, CO ENTERED INTO SECURITIES PURCHASE AGREEMENT - SEC FILING

BRIEF-Sorrento Therapeutics files for mixed shelf of upto $350 mln

* Sorrento Therapeutics Inc files for mixed shelf of upto $350 million - SEC filing‍​ Source text: [http://bit.ly/2yLg1nW] Further company coverage:

BRIEF-Sorrento Therapeutics- ‍Terminated​ deal with Semnur Pharma to purchase all its issued and outstanding equity

* Sorrento Therapeutics - ‍ co, unit Semnur Pharmaceuticals terminated​ deal by which unit would, purchase all of issued and outstanding equity of Semnur Source text: (http://bit.ly/2xYZewg) Further company coverage:

BRIEF-Sorrento Therapeutics files for resale by selling stockholders of up to 754K shares of common stock - SEC filing‍​

* Sorrento Therapeutics Inc - files for resale by selling stockholders of up to 754,930 shares of common stock - SEC filing‍​ Source text: (http://bit.ly/2xTIxlX) Further company coverage:

BRIEF-FDA acknowledges receipt of Sorrento Therapeutics Inc's NDA for Ztlido

* Fda acknowledges receipt of Sorrento Therapeutics Inc, NDA for Ztlido; PDUFA date set for February 28, 2018

BRIEF-Sorrento Therapeutics submits NDA for Ztlido

* Sorrento Therapeutics Inc submits NDA for Ztlido next-generation lidocaine patch

Select another date: